4.5 Article

Carotid Plaque Burden by 3-Dimensional Vascular Ultrasound as a Risk Marker for Patients with Metabolic Syndrome

期刊

出版社

SPRINGER
DOI: 10.1007/s12265-021-10121-z

关键词

Carotid atherosclerosis; Plaque volume; 3D vascular ultrasound; Metabolic syndrome; Cardiovascular risk

资金

  1. Spanish Society of Cardiology Proyecto de investigacion traslacional en cardiologia 2020 [SEC/FEC-INV-TRL 20/007]
  2. Fundacion de Investigacion HM hospitales [I Convocatoria Intramural para grupos emergentes, 2016]
  3. Comunidad de Madrid Government (AORTASANA-CM) [B2017/BMD-3676]
  4. Fondo Social Europeo (FSE)
  5. Instituto de Salud Carlos III, Spain [PI15/02019]
  6. CEU Universities-Banco Santander [MUSPB067]

向作者/读者索取更多资源

This study found that CPB measured by 3DVUS can be a prevalent CV risk marker in MetS subjects, directly associated with CVRF and cardiovascular risk.
Our aim was to analyse the associations between carotid plaque burden (CPB), cardiovascular risk factors (CVRF), and surrogate markers of CV risk in subjects with metabolic syndrome (MetS). We consecutively included 75 asymptomatic outpatients with MetS components, <60 years old and non-smokers. We determined the presence of CVRF, left ventricular hypertrophy (LVH), carotid intima-media thickness (cIMT), albumin-creatinine ratio (ACR), coronary artery calcium score (CACS) and CPB by 3-dimensional vascular ultrasound (3DVUS) for comparison. A total of 50 (67%) subjects had MetS defined by harmonized criteria. A CPB >0 mm(3) and a CACS >0 AU were the risk biomaticers most frequently observed (72% and 77%, respectively), followed by LVH (40%). CPB and CACS revealed association with cardiovascular risk (r = 0.308;p = 0.032 and r = 0.601 p < 0.01, respectively), and CPB also showed association with the burden of CVRF (r = 0.349; p = 0.014). CPB by 3DVUS was a prevalent CV risk marker, directly associated with CVRF and cardiovascular risk in MetS subjects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据